Mark Foletta

(Mr. Mark Foletta CPA)

Currently holds positions in Tocagen Inc, Amylin Pharmaceuticals LLC, AMN Healthcare Services Inc and DexCom Inc

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Tocagen Inc Feb. 1, 2017 -
Chief Financial Officer, Senior Vice President - Finance Amylin Pharmaceuticals LLC March 1, 2006 -
Independent Director AMN Healthcare Services Inc Dec. 12, 2012 -
Lead Independent Director DexCom Inc Nov. 1, 2015 -
Independent Director Regulus Therapeutics Inc Jan. 31, 2013 - April 1, 2018
Interim Chief Financial Officer Biocept Inc Aug. 21, 2015 - July 27, 2016
Independent Director DexCom Inc Nov. 19, 2014 - Nov. 1, 2015
Mark Foletta's trades of DexCom Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-18 2025-06-16
US DexCom Inc (DXCM)
PS Planned sale
2,750 -4.6%
83.13
USD 228,605 		2,750 -4.6% 83.13 USD 228,605
2024-06-20 2024-06-18
US DexCom Inc (DXCM)
PS Planned sale
299 -0.5%
117.25
USD 35,056 		299 -0.5% 117.25 USD 35,056
2024-06-20 2024-06-18
US DexCom Inc (DXCM)
PS Planned sale
3,007 -5.0%
116.75
USD 351,065 		3,007 -5.0% 116.75 USD 351,065
2024-06-20 2024-06-17
US DexCom Inc (DXCM)
PS Planned sale
475 -0.8%
117.77
USD 55,942 		475 -0.8% 117.77 USD 55,942
2024-06-20 2024-06-17
US DexCom Inc (DXCM)
PS Planned sale
2,212 -3.5%
117.16
USD 259,159 		2,212 -3.5% 117.16 USD 259,159
2024-06-20 2024-06-17
US DexCom Inc (DXCM)
PS Planned sale
7 -0.0%
115.18
USD 806 		7 -0.0% 115.18 USD 806
2024-03-01 2024-02-29
B Purchase
500 +6.2%
56.90
USD 28,450 		500 +6.2% 56.90 USD 28,450
2023-04-25 2023-04-21
PS Planned sale
1,458 -15.3%
88.78
USD 129,441 		1,458 -15.3% 88.78 USD 129,441
2023-04-13 2023-04-11
PS Planned sale
1,053 -11.5%
84.63
USD 89,115 		1,053 -11.5% 84.63 USD 89,115
2023-04-13 2023-04-11
PS Planned sale
4,989 -35.3%
84.29
USD 420,523 		4,989 -35.3% 84.29 USD 420,523
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
41 -0.3%
569.54
USD 23,351 		41 -0.3% 569.54 USD 23,351
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
2 -0.0%
567.35
USD 1,135 		2 -0.0% 567.35 USD 1,135
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
87 -0.7%
565.51
USD 49,200 		87 -0.7% 565.51 USD 49,200
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
65 -0.5%
564.24
USD 36,675 		65 -0.5% 564.24 USD 36,675
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
116 -0.9%
562.79
USD 65,283 		116 -0.9% 562.79 USD 65,283
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
78 -0.6%
561.85
USD 43,824 		78 -0.6% 561.85 USD 43,824
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
70 -0.5%
558.78
USD 39,115 		70 -0.5% 558.78 USD 39,115
2021-12-02 2021-12-01
US DexCom Inc (DXCM)
PS Planned sale
41 -0.3%
556.89
USD 22,832 		41 -0.3% 556.89 USD 22,832
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
40 -0.3%
634.01
USD 25,360 		40 -0.3% 634.01 USD 25,360
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
40 -0.3%
631.26
USD 25,250 		40 -0.3% 631.26 USD 25,250
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
42 -0.3%
629.33
USD 26,432 		42 -0.3% 629.33 USD 26,432
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
76 -0.6%
628.41
USD 47,759 		76 -0.6% 628.41 USD 47,759
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
56 -0.4%
627.79
USD 35,156 		56 -0.4% 627.79 USD 35,156
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
7 -0.1%
626.05
USD 4,382 		7 -0.1% 626.05 USD 4,382
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
124 -0.9%
625.32
USD 77,540 		124 -0.9% 625.32 USD 77,540
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
43 -0.3%
624.10
USD 26,836 		43 -0.3% 624.10 USD 26,836
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
13 -0.1%
622.63
USD 8,094 		13 -0.1% 622.63 USD 8,094
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
14 -0.1%
619.32
USD 8,670 		14 -0.1% 619.32 USD 8,670
2021-11-02 2021-11-01
US DexCom Inc (DXCM)
PS Planned sale
45 -0.3%
615.13
USD 27,681 		45 -0.3% 615.13 USD 27,681
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
1 -0.0%
551.58
USD 552 		1 -0.0% 551.58 USD 552
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
51 -0.4%
547.06
USD 27,900 		51 -0.4% 547.06 USD 27,900
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
181 -1.3%
544.39
USD 98,535 		181 -1.3% 544.39 USD 98,535
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
126 -0.9%
543.15
USD 68,437 		126 -0.9% 543.15 USD 68,437
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
88 -0.6%
540.93
USD 47,602 		88 -0.6% 540.93 USD 47,602
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
6 -0.0%
539.10
USD 3,235 		6 -0.0% 539.10 USD 3,235
2021-10-05 2021-10-01
US DexCom Inc (DXCM)
PS Planned sale
47 -0.3%
538.02
USD 25,287 		47 -0.3% 538.02 USD 25,287
2020-11-18 2020-11-16
US DexCom Inc (DXCM)
PS Planned sale
301 -2.2%
342.93
USD 103,222 		301 -2.2% 342.93 USD 103,222
2020-11-18 2020-11-16
US DexCom Inc (DXCM)
PS Planned sale
428 -3.1%
341.79
USD 146,284 		428 -3.1% 341.79 USD 146,284
2020-11-18 2020-11-16
US DexCom Inc (DXCM)
PS Planned sale
117 -0.8%
340.23
USD 39,807 		117 -0.8% 340.23 USD 39,807
2020-11-18 2020-11-16
US DexCom Inc (DXCM)
PS Planned sale
139 -1.0%
337.78
USD 46,951 		139 -1.0% 337.78 USD 46,951
2020-11-18 2020-11-16
US DexCom Inc (DXCM)
PS Planned sale
15 -0.1%
336.98
USD 5,055 		15 -0.1% 336.98 USD 5,055
2020-10-19 2020-10-15
US DexCom Inc (DXCM)
PS Planned sale
208 -1.4%
398.25
USD 82,835 		208 -1.4% 398.25 USD 82,835
2020-10-19 2020-10-15
US DexCom Inc (DXCM)
PS Planned sale
375 -2.5%
397.41
USD 149,030 		375 -2.5% 397.41 USD 149,030
2020-10-19 2020-10-15
US DexCom Inc (DXCM)
PS Planned sale
255 -1.7%
396.51
USD 101,109 		255 -1.7% 396.51 USD 101,109
2020-10-19 2020-10-15
US DexCom Inc (DXCM)
PS Planned sale
120 -0.8%
395.02
USD 47,402 		120 -0.8% 395.02 USD 47,402
// ... existing code ...